Additional drug-gene interactions were observed for APEX1 (Apurinic/Apyrimidinic Endodeoxyribonuclease 1) and N04 drug classification, which comprises of anti-Parkinson drugs, and includes anticholinergic and dopaminergic agents. Here, APEX1 is linked to Parkinson disease.